| John F Moloney, MD | |
|
96 Campus Dr, Suite 1, Scarborough, ME 04074-7133 | |
| (207) 396-5611 | |
| Not Available |
| Full Name | John F Moloney |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 39 Years |
| Location | 96 Campus Dr, Scarborough, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467422980 | NPI | - | NPPES |
| 277880099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD12724 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Light Inland Hospital | Waterville, ME | Hospital |
| Northern Light Mercy Hospital | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Maine Healthcare Systems Inland Hospital | 6305817503 | 75 |
| Mercy Hospital | 6103737812 | 207 |
News Archive
Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat and human brain tissue, published today in eLife.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Patients suffering from dystonia, an uncommon yet potentially crippling movement disorder, get better results if they begin deep brain stimulation therapy sooner rather than later, according to an international study published in the March issue of the Journal of Neurology.
A new study finds middle-aged Americans are now reporting more pain than the elderly - and it has to do with their level of education and that pain is rising more quickly in younger people.
› Verified 6 days ago
| Entity Name | Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629078712 PECOS PAC ID: 6103737812 Enrollment ID: O20040217000943 |
News Archive
Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat and human brain tissue, published today in eLife.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Patients suffering from dystonia, an uncommon yet potentially crippling movement disorder, get better results if they begin deep brain stimulation therapy sooner rather than later, according to an international study published in the March issue of the Journal of Neurology.
A new study finds middle-aged Americans are now reporting more pain than the elderly - and it has to do with their level of education and that pain is rising more quickly in younger people.
› Verified 6 days ago
| Entity Name | Central Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441 |
News Archive
Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat and human brain tissue, published today in eLife.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Patients suffering from dystonia, an uncommon yet potentially crippling movement disorder, get better results if they begin deep brain stimulation therapy sooner rather than later, according to an international study published in the March issue of the Journal of Neurology.
A new study finds middle-aged Americans are now reporting more pain than the elderly - and it has to do with their level of education and that pain is rising more quickly in younger people.
› Verified 6 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104921535 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000274 |
News Archive
Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat and human brain tissue, published today in eLife.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Patients suffering from dystonia, an uncommon yet potentially crippling movement disorder, get better results if they begin deep brain stimulation therapy sooner rather than later, according to an international study published in the March issue of the Journal of Neurology.
A new study finds middle-aged Americans are now reporting more pain than the elderly - and it has to do with their level of education and that pain is rising more quickly in younger people.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat and human brain tissue, published today in eLife.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Patients suffering from dystonia, an uncommon yet potentially crippling movement disorder, get better results if they begin deep brain stimulation therapy sooner rather than later, according to an international study published in the March issue of the Journal of Neurology.
A new study finds middle-aged Americans are now reporting more pain than the elderly - and it has to do with their level of education and that pain is rising more quickly in younger people.
› Verified 6 days ago
| Entity Name | Eastern Maine Healthcare Systems Inland Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376579557 PECOS PAC ID: 6305817503 Enrollment ID: O20040802001656 |
News Archive
Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat and human brain tissue, published today in eLife.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Patients suffering from dystonia, an uncommon yet potentially crippling movement disorder, get better results if they begin deep brain stimulation therapy sooner rather than later, according to an international study published in the March issue of the Journal of Neurology.
A new study finds middle-aged Americans are now reporting more pain than the elderly - and it has to do with their level of education and that pain is rising more quickly in younger people.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John F Moloney, MD 301c Us Route 1, Scarborough, ME 04074-9701 Ph: (207) 396-8600 | John F Moloney, MD 96 Campus Dr, Suite 1, Scarborough, ME 04074-7133 Ph: (207) 396-5611 |
News Archive
Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat and human brain tissue, published today in eLife.
CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.
Patients suffering from dystonia, an uncommon yet potentially crippling movement disorder, get better results if they begin deep brain stimulation therapy sooner rather than later, according to an international study published in the March issue of the Journal of Neurology.
A new study finds middle-aged Americans are now reporting more pain than the elderly - and it has to do with their level of education and that pain is rising more quickly in younger people.
› Verified 6 days ago
Dr. Mary C. Fahrenbach, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 96 Campus Drive, Suite 1, Scarborough, ME 04074 Phone: 207-885-9905 Fax: 207-396-5600 | |
Mark A Wrona, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 51 Us Route 1 Ste I, Scarborough, ME 04074 Phone: 207-303-3300 Fax: 207-250-2139 | |
Dr. Mylan C. Cohen, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 96 Campus Drive, Suite 1, Scarborough, ME 04074 Phone: 207-885-9905 Fax: 207-396-5600 | |
Mirle A Kellett, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 96 Campus Dr, Suite 1, Scarborough, ME 04074 Phone: 207-396-5611 | |
Dr. Warren D Alpern, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 96 Campus Dr, Suite 1, Scarborough, ME 04074 Phone: 207-396-5611 | |
Dr. Eleni Nicole Nackos, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Campus Dr Unit 108, Scarborough, ME 04074 Phone: 207-303-3300 Fax: 207-250-2139 | |
Susan Miesfeldt, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Campus Drive, Suite 110, Scarborough, ME 04074 Phone: 207-396-7678 Fax: 207-396-8766 |